QIAGEN
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
QGEN Key Statistics
QGEN News
Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript April 30, 2024 Qiagen N.V. isn't one of the 30 most popular stocks among hedge funds at the end of the...
Qiagen (QGEN) has released an update. Qiagen N.V. announced its Q1 2024 financial results, surpassing its sales outlook with $462 million at constant exchange...
Qiagen (NYSE:QGEN) First Quarter 2024 Results Key Financial Results Revenue: US$458.8m (down 5.5% from 1Q 2023). Net income: US$80.7m (down 5.1% from 1Q 2023...
Analyst ratings
61%
of 23 ratingsMore QGEN News
QIAGEN N.V.’s QGEN first-quarter 2024 adjusted earnings per share (EPS) were 46 cents and 47 cents at constant exchange rate (CER), down 9.8% year over year. Ho...
For the quarter ended March 2024, Qiagen (QGEN) reported revenue of $458.8 million, down 5.5% over the same period last year. EPS came in at $0.46, compared to...
Reports Q1 revenue $459M, consensus $499.72M. “Our results for the first quarter of 2024 show QIAGEN is on track to achieve the goals that we have set for the y...